The rapid evolution of biomedical science in increasingly translational directions requires that we identify strategies to help the next generation of scientists navigate a complex research landscape in which fluent communication and collaboration between scientific disciplines is essential for success. The Center for Organogenesis at Michigan was formed in 1995 to unite basic, applied and clinical scientists with a common goal: To understand the basic mechanisms by which organs and tissues are formed and maintained, and to use this knowledge to create long-lasting artificial organs, improved stem cell therapies and effective organ transplantation systems that will correct acquired and genetic human diseases. The Training Program in Organogenesis, initiated 14 years ago, is an integral part of the educational mission of the Center. Its goals are: a) To provide intellectual and technical training in the field of organogenesis;and b) To promote interdisciplinary thinking by exposing trainees to research that crosses boundaries between the clinical, basic and applied sciences. These goals are accomplished by encouraging a two-mentor structure for research training and requiring trainees to participate in several specific training activities: a formal course in Organogenesis, Organogenesis Seminar series, Monthly Trainee Meeting, International Symposium. Trainees also actively shape the Training program, proposing new initiatives such as Bioartography, a novel combination of art, science and public education and Crosstalk, a clinical case-based forum run by one clinical and one basic scientist. Additionally, all trainees have the option to be paired with a clinical co-mentor who will facilitae their exposure clinical management of patients and their diseases. This competitive renewal requests support for 5 predoctoral and 3 postdoctoral training slots (one specifically targeted to an M.D. fellow). Trainees come primarily from the laboratories of the 36 listed mentors of the Training Program, all of whom are highly recognized scientists. Formal competitive applications, reviewed by a selection committee, are required for appointment to the Training Program. The Program is monitored by several internal mechanisms and also by two External Advisors (Dr. Blanche Capel, Duke University;Dr. Christopher Wylie, Cincinnati Children's Hospital Medical Center) to ensure its continued responsiveness to demands of a continuously evolving research environment.

Public Health Relevance

Central goals of the Training Program in Organogenesis are: a) To provide intellectual and technical training in the field of organogenesis;and b) To promote interdisciplinary thinking by exposing trainees to research that crosses boundaries between the clinical, basic and applied sciences. Support for 5 predoctoral and 3 postdoctoral fellows per year is requested.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Institutional National Research Service Award (T32)
Project #
5T32HD007505-17
Application #
8462644
Study Section
Special Emphasis Panel (ZHD1-DRG-D (55))
Program Officer
Javois, Lorette Claire
Project Start
1997-05-14
Project End
2017-04-30
Budget Start
2013-05-01
Budget End
2014-04-30
Support Year
17
Fiscal Year
2013
Total Cost
$345,613
Indirect Cost
$23,379
Name
University of Michigan Ann Arbor
Department
Anatomy/Cell Biology
Type
Schools of Medicine
DUNS #
073133571
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Bagchi, Devika P; Forss, Isabel; Mandrup, Susanne et al. (2018) SnapShot: Niche Determines Adipocyte Character II. Cell Metab 27:266-266.e1
Mills, Elizabeth A; Mao-Draayer, Yang (2018) Aging and lymphocyte changes by immunomodulatory therapies impact PML risk in multiple sclerosis patients. Mult Scler 24:1014-1022
Dame, Michael K; Attili, Durga; McClintock, Shannon D et al. (2018) Identification, isolation and characterization of human LGR5-positive colon adenoma cells. Development 145:
Mills, Elizabeth A; Mao-Draayer, Yang (2018) Understanding Progressive Multifocal Leukoencephalopathy Risk in Multiple Sclerosis Patients Treated with Immunomodulatory Therapies: A Bird's Eye View. Front Immunol 9:138
Li, Ziru; Hardij, Julie; Bagchi, Devika P et al. (2018) Development, regulation, metabolism and function of bone marrow adipose tissues. Bone 110:134-140
Trissal, Maria C; Wong, Terrence N; Yao, Juo-Chin et al. (2018) MIR142 Loss-of-Function Mutations Derepress ASH1L to Increase HOXA Gene Expression and Promote Leukemogenesis. Cancer Res 78:3510-3521
Elsaeidi, Fairouz; Macpherson, Peter; Mills, Elizabeth A et al. (2018) Notch Suppression Collaborates with Ascl1 and Lin28 to Unleash a Regenerative Response in Fish Retina, But Not in Mice. J Neurosci 38:2246-2261
Bagchi, Devika P; Forss, Isabel; Mandrup, Susanne et al. (2018) SnapShot: Niche Determines Adipocyte Character I. Cell Metab 27:264-264.e1
Mills, Elizabeth A; Ogrodnik, Magdalena A; Plave, Andrew et al. (2018) Emerging Understanding of the Mechanism of Action for Dimethyl Fumarate in the Treatment of Multiple Sclerosis. Front Neurol 9:5
Bowers, Emily; Slaughter, Anastasiya; Frenette, Paul S et al. (2018) Granulocyte-derived TNF? promotes vascular and hematopoietic regeneration in the bone marrow. Nat Med 24:95-102

Showing the most recent 10 out of 190 publications